Will stick to these trendlines until broken. Ideally looking for a breakdown of support TL and back test making for a great short trade to potential double bottom. If breakout up will most likely be quite sharp as seen with wedge ups. Can make for a great short fade to retest at which point i would watch for long.
Where else can you get a high quality growth stock that is always in need at a value when then the rest of the market is extremely pricey with a trade deal already priced in!? UNH & ANTM NYSE:UNH
UNH and other healthcare stocks such as Anthem, Cigna, etc. could be a potential area that benefits from those flocking from higher volatility areas that have earnings this week that are looking for some high quality value that were once "growth" stocks. I think UNH at least goes back to $250 area within the next week or so. I'm holding call options. Good luck! UNH
If UNH close below the marked RSI uniformity level at the end of the month I would expect a continued down move for health care stocks. -- If we break 208 and hold on the weekly consider an entry with target being the 61.8 retrace and a wide stop around 230. -- Add size on the break and hold below 200. -- Watch sector indexes and leaders regularly to evaluate...
Bounced from 208.80/161.80%. I think falling bio sector is stopped now. However need to watch more.
Downside target reached, but most hold 215 by the end of the week Else not looking good
ACCUMULATION ZONE: 208.57 - 212.42 STOP LOSS: BELOW ACCUMULATION ZONE
Health care being hit hard due to politics, won't affect earnings this year but puts a cloud in the air. Expect short term bounce into earnings
Hello everybody Here is a brief analysis of the Unitedhealth Group. We broke through an important zone of resistance (blue line). Now it is important for me to wait for a return and wait from there for a signal candle which confirms the signal. I think we will see a retrace between the 50s and 78s fibo. However, the course could turn even at the blue support...
MMHVW - see chart. Down 4% in a day.
We love the company but not the recent price action, earnings are approaching and we are sitting on the fence on this one. Recent concerns over medicare has hit the entire sector, on April 16th we can assess the earnings report before taking any position in the stock.
Recent discussions regarding the dismantling of the affordable care act has had quite a negative effect on the sector as a whole. It is our opinion that the stock is still in correction and we have a bias that it will continue higher on a break from the descending triangle.